ROIVANT SCIENCES LTD. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/528d910f-40a9-463e-bf16-7a1ffa33fd11/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $8.3M | 2025-04-01 – 2026-03-31 | evidence 0001635088-26-000061 |
| FY 2024 | $29.1M | 2024-04-01 – 2025-03-31 | evidence 0001140361-25-020715 |
| FY 2023 | $32.7M | 2023-04-01 – 2024-03-31 | evidence 0001140361-25-020715 |
| FY 2022 | $31.5M | 2022-04-01 – 2023-03-31 | evidence 0001140361-25-020715 |
| FY 2021 | $55.3M | 2021-04-01 – 2022-03-31 | evidence 0001193125-22-183362 |
| FY 2020 | $23.8M | 2020-04-01 – 2021-03-31 | evidence 0001193125-22-183362 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ROIVANT SCIENCES LTD. — all facts · Net Income · Operating Income